Table of Contents
Executive Summary — 5
Bangladesh Pharmaceuticals And
Healthcare Industry SWOT — 6
Bangladesh Political
SWOT — 7
Bangladesh Economic SWOT — 7
Bangladesh Business Environment SWOT — 8
Pharmaceutical
Business Environment Ratings — 9
Table: Asia Pacific
Pharmaceutical Business Environment Ratings For Q409 — 9
Limits Of Potential Returns — 10
Risks To Realisation Of
Returns — 10
Market Summary — 12
Regulatory Regime — 13
Table: Steps Required To Establish
Pharmaceutical Manufacturing Unit And Obtain A Drug Manufacturing Licence
(DML) — 13
Counterfeit Drugs — 15
Intellectual Property — 16
Pricing And Reimbursement
Regime — 16
Industry Trends And
Developments — 18
Epidemiology — 18
Healthcare Sector — 20
Contract
Manufacturing — 22
Research And
Development — 23
Table: Suggestions Made By University Of
Dhaka' s Faculty Of Pharmacy To Improve Pharmaceutical Research
Standards — 23
Industry Forecast
Scenario — 24
Overall Market
Forecast — 24
Table: Bangladeshi Drug Market Expenditure,
2003-2013 — 25
Key Growth Factors –
Industry — 26
Table: Bangladesh – Health Expenditure
Indicators, Historical Data and Forecasts — 26
Key Growth
Factors – Macroeconomic — 27
Table: Bangladesh -
Economic Activity, 2006 – 2013 — 29
Prescription
Drug Market Forecast — 30
Table: Bangladeshi Prescription
Drug Market – Data And Forecasts (US$mn, unless otherwise
stated) — 31
Patented Drug Market
Forecast — 32
Table: Bangladeshi Patented Drug Market
– Data And Forecasts — 33
Generics Market
Forecast — 34
Table: Bangladeshi Generics Market –
Data And Forecasts — 34
OTC Drug Market
Forecast — 35
Table: Bangladeshi OTC Drug Market –
Data And Forecasts (BDTmn, unless otherwise stated) — 36
Pharmaceutical Export/Import Forecast — 37
Table:
Bangladeshi Pharmaceutical Export/Import – Data And Forecasts
(US$mn) — 38
Other Healthcare Data
Forecasts — 39
Table: Other Healthcare Data And Forecasts,
2005-2013 — 39
Key Risks To BMI’s
Forecasts — 39
Competitive
Landscape — 40
Recent Activities By Foreign
Companies — 42
Company Profiles — 44
Eskayef Bangladesh — 44
Square
Pharmaceuticals — 46
Renata — 49
Beximco Pharmaceuticals — 51
Country Snapshot: Bangladesh
Demographic Data — 54
Section 1:
Population — 54
Table: Demographic Indicators,
2005-2030 — 54
Table: Rural/Urban Breakdown,
2005-2030 — 55
Section 2: Education And
Healthcare — 55
Table: Education,
2001-2003 — 55
Table: Vital Statistics,
2005-2030 — 55
Section 3: Labour Market And Spending
Power — 56
Table: Employment Indicators,
2001-2006 — 56
Table: Consumer Expenditure, 2000-2010
(US$) — 56
Table: Average Annual Manufacturing
Wages — 57
BMI Forecast Modelling — 58
How We Generate Our Pharmaceutical Industry Forecasts — 58
Pharmaceutical Business Environment Ratings
Methodology — 59
Ratings Overview — 59
Table: Pharmaceutical Business Environment Indicators — 60
Weighting — 61
Table: Weighting Of
Components — 61
Sources — 61
| 
View Cart
